INTELLIA THERAPEUTICS, INC. (NTLA) Operating margin 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) operating margin by fiscal year — reported operating income divided by reported revenue.
-651.7%FY2025 · since FY2016: -195.2% → -651.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -651.7% | +271.4 pp |
| FY2024 | -923.1% | +497.4 pp |
| FY2023 | -1420.5% | -541.5 pp |
| FY2022 | -879.0% | -68.7 pp |
| FY2021 | -810.4% | -574.9 pp |
| FY2020 | -235.5% | +11.3 pp |
| FY2019 | -246.8% | +51.8 pp |
| FY2018 | -298.6% | -32.3 pp |
| FY2017 | -266.3% | -71.2 pp |
| FY2016 | -195.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice